
Pfizer COVID-19 vaccine reduces asymptomatic infection by 94%, data suggests
Fox News
Together with the Israel Ministry of Health, Pfizer and BioNTech announced “real-world evidence” they say demonstrates that their COVID-19 vaccine “dramatically” lowers rates of the coronavirus in inoculated individuals.
"We are extremely encouraged that the real-world effectiveness data coming from Israel are confirming the high efficacy demonstrated in our Phase 3 clinical trial and showing the significant impact of the vaccine in preventing severe disease and deaths due to COVID-19," Luis Jodar, Ph.D., senior vice president and chief medical officer of Pfizer vaccines, said in the press release. "The findings which suggest that the vaccine may also provide protection against asymptomatic SARS-CoV-2 infections are particularly meaningful as we look to disrupt the spread of the virus around the globe. Altogether, these data are critical to understanding the role of vaccination in combatting the pandemic and provide hope to other countries dealing with this devastating disease, which has now afflicted the world for more than a year."More Related News